We combat interconnected cardio-renal-metabolic issues that cause 20 million deaths annually as part of our efforts to address global health threats. Innovative, comprehensive treatments are given priority in our R&D.
Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative health care products
Innovation at Boehringer Ingelheim is driven by patients. Our commitment lies in investigating unaddressed needs and providing revolutionary treatments for upcoming generations.
